Frisco, TX, United States of America

John P McCook

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by John P McCook in Cancer Treatment

Introduction

John P McCook is an accomplished inventor based in Frisco, TX (US). He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of two patents to his name, McCook's work focuses on developing advanced therapeutic methods to combat cancer and its side effects.

Latest Patents

McCook's latest patents include groundbreaking formulations and methods for treating cancer. One of his notable inventions is a cancer cytotoxic exosome formulation that utilizes monocytes activated by β-glucan. This composition aims to treat leukemia by extracting particles such as microvesicles and exosomes from treated monocytes. The resulting cytotoxic composition is designed to induce a cytokine response in the immune system, creating a synergistic effect that enhances cancer treatment outcomes.

Another significant patent addresses chemotherapy-induced alopecia. This invention involves compositions that utilize oxidizers or pro-oxidant compounds to prevent hair loss during chemotherapy. Preferred compositions include organic peroxides, which can be applied to the treatment area before chemotherapy sessions to minimize hair loss.

Career Highlights

John P McCook is associated with JJR&D, LLC, where he continues to innovate in the field of cancer research. His dedication to improving patient outcomes through scientific advancements is evident in his patent portfolio.

Collaborations

McCook collaborates with Joaquin J Jimenez, contributing to the development of innovative solutions in cancer treatment.

Conclusion

John P McCook's contributions to cancer treatment through his innovative patents highlight his commitment to advancing medical science. His work not only addresses the challenges of cancer but also seeks to improve the quality of life for patients undergoing treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…